$CRL, $HLF, $IPHI, $PODD, $MSI, $SPTN
Daily HeffX-LTN reviews dozens of Wall Street’s Key analysts research reports to ID new trading and investing ideas for HeffX-LTN readers. Some reports cover stocks to buy, and others cover stocks to sell or avoid.
Below is our list for Monday, 11 May, as follows:
Charles River Laboratories International Inc. (NYSE:CRL) was reiterated as Buy and its price target was raised to 190 from 165 at Citigroup.
Herbalife Nutrition Ltd. (NYSE:HLF) was reiterated as Buy and its price target was raised to 56 from 49 at Citigroup. Shares closed 41.23 Friday after earnings. Shares have a 48.00 consensus price target.
Inphi Corp. (NASDAQ:IPHI) Needham reiterated its Buy rating and raised its price target to 122 from 100.
Insulet Corp. (NASDAQ:PODD) was reiterated as Buy and its target was raised to 250 from 205 at Citigroup. The stock closed up 217.63 + 1.15% and previously had a 190.06 consensus analyst target.
Motorola Solutions Inc. (NYSE:MSI) was maintained with a Buy rating but its price target was cut to 160 from 175 at Citigroup.
Have a healthy week, Keep the Faith!
Latest posts by Paul Ebeling (see all)
- Gold Price Heads for 3rd Straight Gainer as USD Fades - October 21, 2020
- Sitting on a Cash Pile 6.0? This Growth Story is Compelling - October 21, 2020
- Wednesday’s World Markets Outlook: Asia-Pacific - October 21, 2020